miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. - Test2 - elhamkhani - TriplyDB

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.

http://www.wikidata.org/entity/Q42493425

about

MicroRNA Regulation of Epithelial to Mesenchymal Transition MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)Small non-coding RNAs govern mammary gland tumorigenesis Regulation of mesenchymal phenotype by MicroRNAs in cancer MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential Modeling of miRNA and drug action in the EGFR signaling pathway MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Trail resistance induces epithelial-mesenchymal transition and enhances invasiveness by suppressing PTEN via miR-221 in breast cancer.GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies miR-221/222 control luminal breast cancer tumor progression by regulating different targets.Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees.Trps1 regulates biliary epithelial-mesenchymal transition and has roles during biliary fibrosis in liver grafts: a preliminary study miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1.Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis Non-coding RNAs as regulators of mammary development and breast cancer.miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27(kip1.)Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.Therapeutic evaluation of microRNAs by molecular imaging ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.MicroRNAs and epithelial-mesenchymal transition in prostate cancer.MicroRNA control of epithelial-mesenchymal transition and metastasis.Roles of microRNAs during prostatic tumorigenesis and tumor progression.MicroRNAs in cancer therapeutic response: Friend and foe microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Mir-221/222 are promising targets for innovative anticancer therapy.Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.The relationship between platinum drug resistance and epithelial-mesenchymal transition.Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.Naturally existing isoforms of miR-222 have distinct functions.miRNAs, Melanoma and Microenvironment: An Intricate Network.Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12.

P2860

Q26771110-220D346C-5D10-4F6D-87DB-6AEB8753CBBD Q26853284-946E26A0-4E32-4937-8930-2C6B87177EA6 Q27007057-48BB60F4-421B-424A-A5AF-141BFC278B05 Q27009506-CB5C6F6F-56F0-4ADD-B625-C770DCDEB06F Q28081081-2ED423F1-2A34-4AA0-B5F2-5E13077D5E7F Q28478852-9EDD821E-034B-4059-AB75-6988F8DD83C6 Q33585094-C2A838FF-B3FE-4980-A417-33732393E27E Q33721556-05028305-4E06-4C55-B00D-F635AC75A175 Q33798578-6E69B67E-CF28-4A1C-9DBE-0C46AF6766CA Q33952998-FA8843E3-FDA6-495E-B942-59383D20115C Q34273299-A7D55EE3-13E7-49B0-B691-223EAC79D1F5 Q34490836-76A8AB26-E4E1-48A9-8418-E88F4DD266A0 Q34494526-96C2D837-9D53-4FB0-9345-9D23D375EF38 Q35461630-8CF4F4ED-6B1B-4B59-867E-FC03BE0AD70D Q35619205-23374A21-A101-4612-9C06-6AD090AEB360 Q36172671-CC93A5E1-B928-419D-9863-141F73670F65 Q36729649-E96CFA8A-1E12-4C82-B99A-00D7F589FB17 Q36860719-A4FD8584-3F94-4663-A997-7C52BBD07D59 Q36940253-1562EA2B-C9DD-41BE-836E-59AB40B82A4C Q37211756-0C0BBD49-F6BE-4C0A-820F-7931CC271455 Q37278413-036308C2-22E0-406C-A3D5-D537A684D09D Q37313310-F02B0211-189D-4963-B200-06BD2798535E Q37344798-C847138D-A506-419C-AC04-0D1CD4B4D620 Q37434627-19BC8C1A-82C7-4AFA-B105-F7B20AA25307 Q37641594-1BDEB885-296A-4414-81A1-64E69F651118 Q37643929-454C0C6C-57A4-44C6-A223-2DD720A46A6A Q37687205-F7D096D8-E6AA-4F4D-9260-B87ACA699653 Q38017596-D05138EB-5E28-4F0A-A7C8-7140313D3EBE Q38086009-ECA9FE2D-8F3D-4385-80A0-F43FBC5C7BB2 Q38258754-A439EF77-DDC6-4A12-81DE-2924F6A00944 Q38336073-D4721812-7857-4178-B113-B5497BF704D2 Q38767024-F52F102D-3B23-418E-9CDD-E8CB73932857 Q39001625-9B065607-C1CE-41F2-BE13-5DF1BF1E4881 Q39061847-7E57BFFC-EB2E-45C9-BAE5-717D59D2A54A Q41552639-C64C0247-F348-4721-8385-11A1C9F9CEF0 Q41990770-CE4F40EF-2B4F-4DBE-AA0A-82670EDF2393 Q47152593-701E5230-DA5B-48BB-B416-8E493E29BF79 Q50057521-48E14702-25ED-497F-A839-F63B605C505A Q51415292-7ED59AF5-BA44-4F87-97ED-D5143298DBF3 Q51419186-0C178D4D-2D5D-4DC8-8DB5-4563C151E3A7

P2860

miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.

http://www.wikidata.org/entity/Q42493425

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

miR-221/222 targeting of trich ...... l transition in breast cancer.

@en

miR-221/222 targeting of trichorhinophalangeal 1

@nl

type

label

miR-221/222 targeting of trich ...... l transition in breast cancer.

@en

miR-221/222 targeting of trichorhinophalangeal 1

@nl

prefLabel

miR-221/222 targeting of trich ...... l transition in breast cancer.

@en

miR-221/222 targeting of trichorhinophalangeal 1

@nl

P1433

Q42493425-02710D65-8022-43FF-9815-CC463EC0DDA9

P1476

Q42493425-C9D8EC94-F3D5-4AEF-96A5-206E7D3D0A8F

P2093

Q42493425-02825694-E643-4880-836B-A755D6D75573

Q42493425-0D831990-6CB0-44D8-A785-FA430E24FB8B

Q42493425-0DC7FB5E-99AE-453C-8079-7207492C66A7

Q42493425-15D43972-65EF-40F0-96D6-5DE5AFE44D97

Q42493425-174DC24B-0450-459B-B579-38039F54DFBB

Q42493425-2E5F0ED1-66EB-45FC-B9AF-E36E87A40C2B

Q42493425-397A9388-50E6-434C-8074-F8BBB16D2CF7

Q42493425-3DDAF178-87C6-4703-A73A-5DC4D63089C9

Q42493425-55A4E981-CAFB-46AB-B46C-F9C9322659F0

Q42493425-7720078C-C6FC-4911-A191-425AFE25403B

P2860

Q42493425-0777BA4F-BC81-4BF8-93A8-80D8AE025BDA

Q42493425-1C348F0F-D537-4638-9070-DBCE546EF600

Q42493425-229C9BA8-E6F6-4E87-B2A7-48DEE0F06DFD

Q42493425-28758D29-1A54-4E77-B5DB-C4DE34F8D0C1

Q42493425-30022EC5-F717-4554-AF6E-7CF66194E375

Q42493425-7771A14C-2287-4558-ABFB-412EFF01C7ED

Q42493425-8E33A5D4-6F7C-47CB-AE2E-E5B28806FE8F

Q42493425-98AAB438-3F5C-4553-8315-1E0CA3E867FC

Q42493425-A6604469-DCC0-4CDD-95D4-54CAF2DAA9D3

Q42493425-ACC5E529-E3CA-49F6-A9BD-BD196D4AD4E2

P304

Q42493425-52E50991-C4F4-47EB-AB93-076AFF8A90B1

P31

Q42493425-8FA7B463-5C46-4014-B8C0-501F93247C06

P356

Q42493425-25F04B66-1DF5-4CDF-AB99-DF20C0FA54F7

P433

Q42493425-CBB59D09-51EA-4904-9B1C-4CF035D893D2

P478

Q42493425-0A4DE27F-CEC4-4244-8884-537138F4D96A

P50

Q42493425-1B38768B-DFAB-4945-BED2-AF68999071B9

Q42493425-DA6EC18A-0EC7-4140-8844-7E7630260648

Q42493425-EA6965FE-F5D0-4273-A3C1-3DBE2AAA4A0C

Q42493425-F769810D-932E-4C89-8B26-F17FDD67A3DB

P577

Q42493425-7A3CBF1F-1A16-40EF-A120-072ED3CF50E3

P698

Q42493425-84433742-2A0A-4144-8244-08B323B7497F

P356

SCISIGNAL.2002258

P1433

Science Signaling

P1476

miR-221/222 targeting of trich ...... l transition in breast cancer.

@en

P2093

Alex T Adai

http://www.w3.org/2001/XMLSchema#string

Carol O'Brien

http://www.w3.org/2001/XMLSchema#string

David Dornan

http://www.w3.org/2001/XMLSchema#string

Frederic J de Sauvage

http://www.w3.org/2001/XMLSchema#string

Howard M Stern

http://www.w3.org/2001/XMLSchema#string

Hyo-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Jill Spoerke

http://www.w3.org/2001/XMLSchema#string

Lukas Amler

http://www.w3.org/2001/XMLSchema#string

Nancy Yu

http://www.w3.org/2001/XMLSchema#string

Peng Yue

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

The epithelial-mesenchymal transition generates cells with properties of stem cells

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

Epithelial-mesenchymal transitions in tumour progression

Mammalian microRNAs predominantly act to decrease target mRNA levels

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

P304

pt5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCISIGNAL.2002258

http://www.w3.org/2001/XMLSchema#string

P433

186

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Richard Bourgon

Mark R. Lackner

P577

2011-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21868360

http://www.w3.org/2001/XMLSchema#string